Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 288

1.

Management of non-severe pregnancy hypertension - A summary of the CHIPS Trial (Control of Hypertension in Pregnancy Study) research publications.

Magee LA, Rey E, Asztalos E, Hutton E, Singer J, Helewa M, Lee T, Logan AG, Ganzevoort W, Welch R, Thornton JG, von Dadelszen P.

Pregnancy Hypertens. 2019 Oct 14;18:156-162. doi: 10.1016/j.preghy.2019.08.166. [Epub ahead of print]

PMID:
31627057
2.

PREPARE: protocol for a stepped wedge trial to evaluate whether a risk stratification model can reduce preterm deliveries among women with suspected or confirmed preterm pre-eclampsia.

Dias MAB, De Oliveira L, Jeyabalan A, Payne B, Redman CW, Magee L, Poston L, Chappell L, Seed P, von Dadelszen P, Roberts JM; PREPARE Research Group.

BMC Pregnancy Childbirth. 2019 Oct 7;19(1):343. doi: 10.1186/s12884-019-2445-x.

3.

A prediction model for short-term neonatal outcomes in severe early-onset fetal growth restriction.

Sharp A, Jackson R, Cornforth C, Harrold J, Turner MA, Kenny L, Baker PN, Johnstone ED, Khalil A, von Dadelszen P, Papageorghiou AT, Alfirevic Z.

Eur J Obstet Gynecol Reprod Biol. 2019 Oct;241:109-118. doi: 10.1016/j.ejogrb.2019.08.007. Epub 2019 Aug 16.

PMID:
31499415
4.

Self-reported maternal morbidity: Results from the community level interventions for pre-eclampsia (CLIP) baseline survey in Sindh, Pakistan.

Sheikh S, Qureshi RN, Raza F, Memon J, Ahmed I, Vidler M, Payne BA, Lee T, Sawchuck D, Magee L, von Dadelszen P, Bhutta Z; CLIP Working Group.

Pregnancy Hypertens. 2019 Jul;17:113-120. doi: 10.1016/j.preghy.2019.05.016. Epub 2019 May 17.

5.

Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early-onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo-controlled double-blind trial.

Khalil A, Sharp A, Cornforth C, Jackson R, Mousa H, Stock S, Harrold J, Turner MA, Kenny LC, Baker PN, Johnstone ED, von Dadelszen P, Magee L, Papageorghiou AT, Alfirevic Z.

Ultrasound Obstet Gynecol. 2019 Aug 20. doi: 10.1002/uog.20851. [Epub ahead of print]

PMID:
31432556
6.

Mothers' satisfaction with care during facility-based childbirth: a cross-sectional survey in southern Mozambique.

Mocumbi S, Högberg U, Lampa E, Sacoor C, Valá A, Bergström A, von Dadelszen P, Munguambe K, Hanson C, Sevene E; CLIP working group.

BMC Pregnancy Childbirth. 2019 Aug 19;19(1):303. doi: 10.1186/s12884-019-2449-6.

7.

Erratum to "The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention" [Int J Gynecol Obstet 145 Suppl. 1 (2019) 1-33].

Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, McAuliffe F, da Silva Costa F, von Dadelszen P, McIntyre HD, Kihara AB, Di Renzo GC, Romero R, D'Alton M, Berghella V, Nicolaides KH, Hod M.

Int J Gynaecol Obstet. 2019 Sep;146(3):390-391. doi: 10.1002/ijgo.12892. Epub 2019 Jun 22. No abstract available.

PMID:
31378938
8.

Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.

Easterling T, Mundle S, Bracken H, Parvekar S, Mool S, Magee LA, von Dadelszen P, Shochet T, Winikoff B.

Lancet. 2019 Sep 21;394(10203):1011-1021. doi: 10.1016/S0140-6736(19)31282-6. Epub 2019 Aug 1.

9.

How accurate are modelled birth and pregnancy estimates? Comparison of four models using high resolution maternal health census data in southern Mozambique.

Dube YP, Ruktanonchai CW, Sacoor C, Tatem AJ, Munguambe K, Boene H, Vilanculo FC, Sevene E, Matthews Z, von Dadelszen P, Makanga PT.

BMJ Glob Health. 2019 Jul 1;4(Suppl 5):e000894. doi: 10.1136/bmjgh-2018-000894. eCollection 2019.

10.

The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.

Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, McAuliffe F, da Silva Costa F, von Dadelszen P, McIntyre HD, Kihara AB, Di Renzo GC, Romero R, D'Alton M, Berghella V, Nicolaides KH, Hod M.

Int J Gynaecol Obstet. 2019 May;145 Suppl 1:1-33. doi: 10.1002/ijgo.12802. Erratum in: Int J Gynaecol Obstet. 2019 Sep;146(3):390-391.

PMID:
31111484
11.

The incidence of pregnancy hypertension in India, Pakistan, Mozambique, and Nigeria: A prospective population-level analysis.

Magee LA, Sharma S, Nathan HL, Adetoro OO, Bellad MB, Goudar S, Macuacua SE, Mallapur A, Qureshi R, Sevene E, Sotunsa J, Valá A, Lee T, Payne BA, Vidler M, Shennan AH, Bhutta ZA, von Dadelszen P; CLIP Study Group.

PLoS Med. 2019 Apr 12;16(4):e1002783. doi: 10.1371/journal.pmed.1002783. eCollection 2019 Apr.

12.

No 376 - Recours au sulfate de magnésium aux fins de neuroprotection fœtale.

Magee LA, De Silva DA, Sawchuck D, Synnes A, von Dadelszen P.

J Obstet Gynaecol Can. 2019 Apr;41(4):523-542. doi: 10.1016/j.jogc.2018.11.033.

PMID:
30879486
13.

No. 376-Magnesium Sulphate for Fetal Neuroprotection.

Magee LA, De Silva DA, Sawchuck D, Synnes A, von Dadelszen P.

J Obstet Gynaecol Can. 2019 Apr;41(4):505-522. doi: 10.1016/j.jogc.2018.09.018.

PMID:
30879485
14.

Ready for prime time - prediction of preterm pre-eclampsia.

von Dadelszen P.

BJOG. 2019 Jul;126(8):971. doi: 10.1111/1471-0528.15680. Epub 2019 Apr 1. No abstract available.

PMID:
30864241
15.

Temporal and external validation of the fullPIERS model for the prediction of adverse maternal outcomes in women with pre-eclampsia.

Ukah UV, Payne B, Karjalainen H, Kortelainen E, Seed PT, Conti-Ramsden FI, Cao V, Laivuori H, Hutcheon J, Chappell L, Mark Ansermino J, Vatish M, Redman C, Lee T, Li L, Magee LA, von Dadelszen P; fullPIERS Group.

Pregnancy Hypertens. 2019 Jan;15:42-50. doi: 10.1016/j.preghy.2018.01.004. Epub 2018 Jan 5.

16.

Policy review on the management of pre-eclampsia and eclampsia by community health workers in Mozambique.

Macuácua S, Catalão R, Sharma S, Valá A, Vidler M, Macete E, Sidat M, Munguambe K, von Dadelszen P, Sevene E; CLIP Working Group.

Hum Resour Health. 2019 Feb 28;17(1):15. doi: 10.1186/s12960-019-0353-9. Review.

17.

Place-specific factors associated with adverse maternal and perinatal outcomes in Southern Mozambique: a retrospective cohort study.

Makanga PT, Sacoor C, Schuurman N, Lee T, Vilanculo FC, Munguambe K, Boene H, Ukah UV, Vidler M, Magee LA, Sevene E, von Dadelszen P, Firoz T; CLIP Working Group.

BMJ Open. 2019 Feb 19;9(2):e024042. doi: 10.1136/bmjopen-2018-024042.

18.

Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction.

Sharp A, Cornforth C, Jackson R, Harrold J, Turner MA, Kenny L, Baker PN, Johnstone ED, Khalil A, von Dadelszen P, Papageorghiou AT, Alfirevic Z.

Lancet Child Adolesc Health. 2019 Mar;3(3):e2-e3. doi: 10.1016/S2352-4642(19)30020-3. Epub 2019 Jan 29. No abstract available.

PMID:
30704877
19.

Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial.

Hofmeyr GJ, Betrán AP, Singata-Madliki M, Cormick G, Munjanja SP, Fawcus S, Mose S, Hall D, Ciganda A, Seuc AH, Lawrie TA, Bergel E, Roberts JM, von Dadelszen P, Belizán JM; Calcium and Pre-eclampsia Study Group.

Lancet. 2019 Jan 26;393(10169):330-339. doi: 10.1016/S0140-6736(18)31818-X.

20.

CHIPS-Child: Testing the developmental programming hypothesis in the offspring of the CHIPS trial.

Magee LA, Synnes AR, von Dadelszen P, Hutfield AM, Chanoine JP, Côté AM, Devlin AM, Dorling J, Gafni A, Ganzevoort W, Helewa ME, Hutton EK, Koren G, Lee SK, Mcarthur D, Rey E, Robinson WP, Roseboom TJ, Singer J, Wilson S, Moutquin JM; CHIPS-Child Study Group (Table S1).

Pregnancy Hypertens. 2018 Oct;14:15-22. doi: 10.1016/j.preghy.2018.04.021. Epub 2018 May 19.

21.

A comparison of maternal and newborn health services costs in Sindh Pakistan.

Khowaja AR, Mitton C, Qureshi R, Bryan S, Magee LA, von Dadelszen P, Bhutta ZA.

PLoS One. 2018 Dec 6;13(12):e0208299. doi: 10.1371/journal.pone.0208299. eCollection 2018.

22.

Viagra for fetal growth restriction: STRIDER Consortium replies to letter by Symonds and Budge.

Kenny LC, Alfirevic Z, Baker PN, Ganzevoort W, Gluud C, Groom KM, Jakobsen JC, Lim K, Magee LA, Papageorghiou AT, von Dadelszen P.

BMJ. 2018 Nov 22;363:k4872. doi: 10.1136/bmj.k4872. No abstract available.

PMID:
30467195
23.

State-of-the-Art Diagnosis and Treatment of Hypertension in Pregnancy.

Magee LA, von Dadelszen P.

Mayo Clin Proc. 2018 Nov;93(11):1664-1677. doi: 10.1016/j.mayocp.2018.04.033. Review.

PMID:
30392546
24.

Characterization of maternal plasma biomarkers associated with delivery of small and large for gestational age infants in the MIREC study cohort.

Kumarathasan P, Williams G, Bielecki A, Blais E, Hemmings DG, Smith G, von Dadelszen P, Fisher M, Arbuckle TE, Fraser WD, Vincent R.

PLoS One. 2018 Nov 1;13(11):e0204863. doi: 10.1371/journal.pone.0204863. eCollection 2018.

25.

Development and internal validation of the multivariable CIPHER (Collaborative Integrated Pregnancy High-dependency Estimate of Risk) clinical risk prediction model.

Payne BA, Ryan H, Bone J, Magee LA, Aarvold AB, Mark Ansermino J, Bhutta ZA, Bowen M, Guilherme Cecatti J, Chazotte C, Crozier T, de Pont AJM, Demirkiran O, Duan T, Kallen M, Ganzevoort W, Geary M, Goffman D, Hutcheon JA, Joseph KS, Lapinsky SE, Lataifeh I, Li J, Liskonova S, Hamel EM, McAuliffe FM, O'Herlihy C, Mol BWJ, Seaward PGR, Tadros R, Togal T, Qureshi R, Vivian Ukah U, Vasquez D, Wallace E, Yong P, Zhou V, Walley KR, von Dadelszen P; CIPHER Group.

Crit Care. 2018 Oct 30;22(1):278. doi: 10.1186/s13054-018-2215-6.

26.

Tackling poorly selected, collected, and reported outcomes in obstetrics and gynecology research.

Duffy JMN, Ziebland S, von Dadelszen P, McManus RJ.

Am J Obstet Gynecol. 2019 Jan;220(1):71.e1-71.e4. doi: 10.1016/j.ajog.2018.09.023. Epub 2018 Sep 28. Review.

PMID:
30273584
27.

Creating biobanks in low and middle-income countries to improve knowledge - The PREPARE initiative.

De Oliveira L, Dias MAB, Jeyabalan A, Payne B, Redman CW, Magee L, Poston L, Chappell L, Seed P, von Dadelszen P, Roberts JM.

Pregnancy Hypertens. 2018 Jul;13:62-64. doi: 10.1016/j.preghy.2018.05.007. Epub 2018 May 24.

28.

Activated protein C as disease-modifying therapy in antenatal preeclampsia: An open-label, single arm safety and efficacy trial.

von Dadelszen P, Magee LA, Benton SJ, Hu Y, Ansermino JM, Carleton B, Carter C, Douglas MJ, Janssen PA, Lee SK, Leung PCK, Li J, MacNab Y, Payne BA, Peng G, Rodger M, Skoll MA, Synnes A, Walley KR, Russell JA.

Pregnancy Hypertens. 2018 Jul;13:121-126. doi: 10.1016/j.preghy.2018.05.009. Epub 2018 May 28.

29.

Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial.

Sharp A, Cornforth C, Jackson R, Harrold J, Turner MA, Kenny LC, Baker PN, Johnstone ED, Khalil A, von Dadelszen P, Papageorghiou AT, Alfirevic Z; STRIDER group.

Lancet Child Adolesc Health. 2018 Feb;2(2):93-102. doi: 10.1016/S2352-4642(17)30173-6. Epub 2017 Dec 7. Erratum in: Lancet Child Adolesc Health. 2018 Feb;2(2):e2.

30.

Availability and use of magnesium sulphate at health care facilities in two selected districts of North Karnataka, India.

Katageri G, Charantimath U, Joshi A, Vidler M, Ramadurg U, Sharma S, Bannale S, Payne BA, Rakaraddi S, Karadiguddi C, Mungarwadi G, Kavi A, Sawchuck D, Derman R, Goudar S, Mallapur A, Bellad M, Magee LA, Qureshi R, von Dadelszen P; Community Level Interventions for Pre-eclampsia (CLIP) India Feasibility Working Group.

Reprod Health. 2018 Jun 22;15(Suppl 1):91. doi: 10.1186/s12978-018-0531-6.

31.

The feasibility of task-sharing the identification, emergency treatment, and referral for women with pre-eclampsia by community health workers in India.

Charanthimath U, Vidler M, Katageri G, Ramadurg U, Karadiguddi C, Kavi A, Joshi A, Mungarwadi G, Bannale S, Rakaraddi S, Sawchuck D, Qureshi R, Sharma S, Payne BA, von Dadelszen P, Derman R, Magee LA, Goudar S, Mallapur A, Bellad M; and the Community Level Interventions for Pre-eclampsia (CLIP) India Feasibility Working Group, Bhutta Z, Naik S, Mulla A, Kamle N, Dhamanekar V, Drebit SK, Kariya C, Lee T, Li J, Lui M, Khowaja AR, Tu DK, Revankar A.

Reprod Health. 2018 Jun 22;15(Suppl 1):101. doi: 10.1186/s12978-018-0532-5.

32.

The impact of hypertension, hemorrhage, and other maternal morbidities on functioning in the postpartum period as assessed by the WHODAS 2.0 36-item tool.

Guida JP, Costa ML, Parpinelli MA, Pacagnella RC, Ferreira EC, Mayrink J, Silveira C, Souza RT, Sousa MH, Say L, Chou D, Filippi V, Barreix M, Barbour K, McCaw-Binns A, von Dadelszen P, Cecatti JG; Brazilian Cohort on Severe Maternal Morbidity (COMMAG) study group and the WHO Maternal Morbidity Working Group (MMWG).

Int J Gynaecol Obstet. 2018 May;141 Suppl 1:55-60. doi: 10.1002/ijgo.12467.

33.

Validation of the WHO Disability Assessment Schedule (WHODAS 2.0) 12-item tool against the 36-item version for measuring functioning and disability associated with pregnancy and history of severe maternal morbidity.

Silveira C, Souza RT, Costa ML, Parpinelli MA, Pacagnella RC, Ferreira EC, Mayrink J, Guida JP, Sousa MH, Say L, Chou D, Filippi V, Barreix M, Barbour K, Firoz T, von Dadelszen P, Cecatti JG; Brazilian Cohort on Severe Maternal Morbidity (COMMAG) study group and the WHO Maternal Morbidity Working Group (MMWG).

Int J Gynaecol Obstet. 2018 May;141 Suppl 1:39-47. doi: 10.1002/ijgo.12465.

34.

Reference ranges of the WHO Disability Assessment Schedule (WHODAS 2.0) score and diagnostic validity of its 12-item version in identifying altered functioning in healthy postpartum women.

Mayrink J, Souza RT, Silveira C, Guida JP, Costa ML, Parpinelli MA, Pacagnella RC, Ferreira EC, Sousa MH, Say L, Chou D, Filippi V, Barreix M, Barbour K, von Dadelszen P, Cecatti JG; Brazilian Cohort on Severe Maternal Morbidity (COMMAG) study group and the WHO Maternal Morbidity Working Group (MMWG).

Int J Gynaecol Obstet. 2018 May;141 Suppl 1:48-54. doi: 10.1002/ijgo.12466.

35.

Placental growth factor as an indicator of fetal growth restriction in late-onset small-for-gestational age pregnancies.

Anderson N, De Laat M, Benton S, von Dadelszen P, McCowan L.

Aust N Z J Obstet Gynaecol. 2019 Feb;59(1):89-95. doi: 10.1111/ajo.12831. Epub 2018 May 31.

PMID:
29851029
36.

Influence of Gestational Age at Initiation of Antihypertensive Therapy: Secondary Analysis of CHIPS Trial Data (Control of Hypertension in Pregnancy Study).

Pels A, Mol BWJ, Singer J, Lee T, von Dadelszen P, Ganzevoort W, Asztalos E, Magee LA; CHIPS Study Group.

Hypertension. 2018 Jun;71(6):1170-1177. doi: 10.1161/HYPERTENSIONAHA.117.10689. Epub 2018 Apr 23.

37.

Early diagnosis of preeclampsia using placental growth factor: An operational pilot study in Maputo, Mozambique.

Manriquez Rocha B, Mbofana F, Loquiha O, Mudenyanga C, Ukah UV, Magee LA, von Dadelszen P.

Pregnancy Hypertens. 2018 Jan;11:26-31. doi: 10.1016/j.preghy.2017.12.005. Epub 2017 Dec 24.

PMID:
29523269
38.

Assessment of the fullPIERS Risk Prediction Model in Women With Early-Onset Preeclampsia.

Ukah UV, Payne B, Hutcheon JA, Ansermino JM, Ganzevoort W, Thangaratinam S, Magee LA, von Dadelszen P.

Hypertension. 2018 Apr;71(4):659-665. doi: 10.1161/HYPERTENSIONAHA.117.10318. Epub 2018 Feb 12.

39.

Health and socio-demographic profile of women of reproductive age in rural communities of southern Mozambique.

Sacoor C, Payne B, Augusto O, Vilanculo F, Nhacolo A, Vidler M, Makanga PT, Munguambe K, Lee T, Macete E, von Dadelszen P, Sevene E; CLIP Working Group.

PLoS One. 2018 Feb 2;13(2):e0184249. doi: 10.1371/journal.pone.0184249. eCollection 2018.

40.

MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)-implementation of a national guideline in Canada.

De Silva DA, Synnes AR, von Dadelszen P, Lee T, Bone JN; MAG-CP, CPN and CNN collaborative groups, Magee LA.

Implement Sci. 2018 Jan 11;13(1):8. doi: 10.1186/s13012-017-0702-9.

41.

The CRADLE vital signs alert: qualitative evaluation of a novel device designed for use in pregnancy by healthcare workers in low-resource settings.

Nathan HL, Boene H, Munguambe K, Sevene E, Akeju D, Adetoro OO, Charanthimath U, Bellad MB, de Greeff A, Anthony J, Hall DR, Steyn W, Vidler M, von Dadelszen P, Chappell LC, Sandall J, Shennan AH; CLIP Working Group.

Reprod Health. 2018 Jan 5;15(1):5. doi: 10.1186/s12978-017-0450-y.

42.

STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials.

Pels A, Kenny LC, Alfirevic Z, Baker PN, von Dadelszen P, Gluud C, Kariya CT, Mol BW, Papageorghiou AT, van Wassenaer-Leemhuis AG, Ganzevoort W, Groom KM; international STRIDER Consortium.

BMC Pregnancy Childbirth. 2017 Dec 28;17(1):440. doi: 10.1186/s12884-017-1594-z.

43.

Determinants of magnesium sulphate use in women hospitalized at <29 weeks with severe or non-severe pre-eclampsia.

De Silva DA, Proctor L, von Dadelszen P, McCoach M, Lee T; Canadian Perinatal Network (CPN) Collaborative Group, Magee LA.

PLoS One. 2017 Dec 22;12(12):e0189966. doi: 10.1371/journal.pone.0189966. eCollection 2017.

44.

Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review.

Ukah UV, De Silva DA, Payne B, Magee LA, Hutcheon JA, Brown H, Ansermino JM, Lee T, von Dadelszen P.

Pregnancy Hypertens. 2018 Jan;11:115-123. doi: 10.1016/j.preghy.2017.11.006. Epub 2017 Nov 21. Review.

45.

Obstetric fistulae in southern Mozambique: incidence, obstetric characteristics and treatment.

Mocumbi S, Hanson C, Högberg U, Boene H, von Dadelszen P, Bergström A, Munguambe K, Sevene E; CLIP working group.

Reprod Health. 2017 Nov 10;14(1):147. doi: 10.1186/s12978-017-0408-0.

46.

Placental Growth Factor as a Prognostic Tool in Women With Hypertensive Disorders of Pregnancy: A Systematic Review.

Ukah UV, Hutcheon JA, Payne B, Haslam MD, Vatish M, Ansermino JM, Brown H, Magee LA, von Dadelszen P.

Hypertension. 2017 Dec;70(6):1228-1237. doi: 10.1161/HYPERTENSIONAHA.117.10150. Epub 2017 Oct 30. Review.

47.

External validation, update and development of prediction models for pre-eclampsia using an Individual Participant Data (IPD) meta-analysis: the International Prediction of Pregnancy Complication Network (IPPIC pre-eclampsia) protocol.

Allotey J, Snell KIE, Chan C, Hooper R, Dodds J, Rogozinska E, Khan KS, Poston L, Kenny L, Myers J, Thilaganathan B, Chappell L, Mol BW, Von Dadelszen P, Ahmed A, Green M, Poon L, Khalil A, Moons KGM, Riley RD, Thangaratinam S; IPPIC Collaborative Network.

Diagn Progn Res. 2017 Oct 3;1:16. doi: 10.1186/s41512-017-0016-z. eCollection 2017.

48.

Timing of delivery in a high-risk obstetric population: a clinical prediction model.

De Silva DA, Lisonkova S, von Dadelszen P, Synnes AR; Canadian Perinatal Network (CPN) Collaborative Group, Magee LA.

BMC Pregnancy Childbirth. 2017 Jun 29;17(1):202. doi: 10.1186/s12884-017-1390-9.

49.

SOCIETAL PERSPECTIVE ON COST DRIVERS FOR HEALTH TECHNOLOGY ASSESSMENT IN SINDH, PAKISTAN.

Khowaja AR, Mitton C, Qureshi R, Bryan S, Magee LA, von Dadelszen P, Bhutta ZA.

Int J Technol Assess Health Care. 2017 Jan;33(2):192-198. doi: 10.1017/S0266462317000320. Epub 2017 Jun 7.

50.

Validating the Performance of the Modified Early Obstetric Warning System Multivariable Model to Predict Maternal Intensive Care Unit Admission.

Ryan HM, Jones MA, Payne BA, Sharma S, Hutfield AM, Lee T, Ukah UV, Walley KR, Magee LA, von Dadelszen P.

J Obstet Gynaecol Can. 2017 Sep;39(9):728-733.e3. doi: 10.1016/j.jogc.2017.01.028. Epub 2017 May 26.

Supplemental Content

Loading ...
Support Center